MedTrace Logo

CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

NCT02091557 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2014-07-01

No results posted yet for this study

Summary

To assess the diagnostic accuracy for the noninvasive detection of pelvic endometriosis of the combination of two simple parameters: modifications of serum CA 125 and VAS pain score following one dose of GnRH-analog (GnRH-a).

Conditions

  • Pelvic Pain
  • Endometriosis

Interventions

DRUG

GnRH-analogue

Sponsors & Collaborators

  • University Magna Graecia

    lead OTHER

Principal Investigators

  • Fulvio Zullo · Magna Graecia University of Catanzaro

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02091557 on ClinicalTrials.gov